Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Sep;110(1):20–22. doi: 10.1111/j.1476-5381.1993.tb13765.x

Release-regulating dopamine autoreceptors in human cerebral cortex.

E Fedele 1, G C Andrioli 1, A Ruelle 1, M Raiteri 1
PMCID: PMC2176017  PMID: 8106101

Abstract

Slices from fresh specimens of human neocortex which had to be removed during neurosurgery to reach subcortical tumours were labelled with [3H]-dopamine and stimulated electrically. Quinpirole, a selective dopamine D2 receptor agonist, inhibited the stimulated tritium overflow (EC50 = 25 nM; maximal inhibition: about 80% at 10 microM). The selective D1 receptor agonist, SKF 38393, was inactive up to 10 microM. Quinpirole was antagonized by the D2 receptor antagonist (-)-sulpiride (apparent pA2 = 8.26). Thus dopaminergic axon terminals in the human mesocortical pathway possess autoreceptors of the D2 type.

Full text

PDF
20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Keyser J. Subtypes and localization of dopamine receptors in human brain. Neurochem Int. 1993 Feb;22(2):83–93. doi: 10.1016/0197-0186(93)90001-l. [DOI] [PubMed] [Google Scholar]
  2. Hetey L., Schwitzkowsky R., Ott T., Barz H. Diminished synaptosomal dopamine (DA) release and DA autoreceptor supersensitivity in schizophrenia. J Neural Transm Gen Sect. 1991;83(1-2):25–35. doi: 10.1007/BF01244449. [DOI] [PubMed] [Google Scholar]
  3. Hoffmann I. S., Talmaciu R. K., Ferro C. P., Cubeddu L. X. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. J Pharmacol Exp Ther. 1988 Jun;245(3):761–772. [PubMed] [Google Scholar]
  4. Plantjé J. F., Dijcks F. A., Verheijden P. F., Stoof J. C. Stimulation of D-2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine. Eur J Pharmacol. 1985 Aug 27;114(3):401–402. doi: 10.1016/0014-2999(85)90388-7. [DOI] [PubMed] [Google Scholar]
  5. Raiteri M., Bonanno G., Maura G., Pende M., Andrioli G. C., Ruelle A. Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex. Br J Pharmacol. 1992 Dec;107(4):1146–1151. doi: 10.1111/j.1476-5381.1992.tb13421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Starke K., Göthert M., Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989 Jul;69(3):864–989. doi: 10.1152/physrev.1989.69.3.864. [DOI] [PubMed] [Google Scholar]
  7. Starke K., Späth L., Lang J. D., Adelung C. Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):298–306. doi: 10.1007/BF00512467. [DOI] [PubMed] [Google Scholar]
  8. Talmaciu R. K., Hoffmann I. S., Cubeddu L. X. Dopamine autoreceptors modulate dopamine release from the prefrontal cortex. J Neurochem. 1986 Sep;47(3):865–870. doi: 10.1111/j.1471-4159.1986.tb00691.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES